Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.1.2022Adamed Pharma S.A. (AFD)2991BRAMIZEK 10 mg/10 mg tvrdé kapsuly (cps dur 98x10 mg/10 mg (blis.PA/Al/PVC/Al))31.1.2022Z
 11.1.2022Adamed Pharma S.A. (AFD)9878BCandezek 16 mg/5 mg (cps dur 30x16 mg/5 mg (blis.PA/Al/PVC/Al))28.1.2022Z
 11.1.2022TAD Pharma GmbH (TPW-D-2)04625Atoridor 80 mg (tbl flm 30x80 mg (blis.OPA/Al/PVC/Al))10.1.2022O
 11.1.2022Viatris Healthcare Limited (VIM-1)6610BCholib 145 mg/20 mg filmom obalené tablety (tbl flm 90x145 mg/20 mg (blis.Al/Al))12.1.2022O
 11.1.2022Mylan Ireland Limited (MNY)0877APerindopril Mylan 4 mg (tbl 30x4 mg (blis.Al/OPA/PVC/Al))12.1.2022O
 10.1.2022INN-FARM d.o.o. (IAR)6288BCefixime InnFarm 100 mg/5 ml granulát na perorálnu suspenziu (gru por 1x100 ml (fľ.skl.hnedá+1xPP odmerka+1xstriek.))10.1.2022R
 10.1.2022Upjohn EESV (UPO-NL)83099XANAX SR 0,5 mg (tbl plg 30x0,5 mg (blis.PA/Al/PVC))10.1.2022O
 10.1.2022Upjohn EESV (UPO-NL)90959XANAX 0,5 mg (tbl 30x0,5 mg (blis.PVC/Al))10.1.2022O
 10.1.2022Upjohn EESV (UPO-NL)83100XANAX SR 1 mg (tbl plg 30x1 mg (blis.PA/Al/PVC))10.1.2022O
 10.1.2022Upjohn EESV (UPO-NL)96977XANAX 1 mg (tbl 30x1 mg (blis.PVC/Al))10.1.2022O
 10.1.2022Upjohn EESV (UPO-NL)90957XANAX 0,25 mg (tbl 30x0,25 mg (blis.PVC/Al))10.1.2022O
 10.1.2022TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)96813Sumamed 500 mg (tbl flm 3x500 mg (blis.PVC/Al))24.1.2022R
 10.1.2022Zentiva k.s. (ZNT-3)9369BReseligo 3,6 mg (imp sip 1x3,6 mg (aplik.inj.ihl.+implantát))10.1.2022R
 10.1.2022Zentiva, k.s. (ZNT-1)28950ZODAC (tbl flm 10x10 mg (blis.PVC/PVDC/Al))10.1.2022R
 10.1.2022Zentiva, k.s. (ZNT-1)84766Rosucard 40 mg filmom obalené tablety (tbl flm 30x40 mg (blis.OPA/Al/PVC/Al))10.1.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)